Plaque Psoriasis
Symptoms, Doctors, Treatments, Advances & More

Plaque Psoriasis Overview

Save information for later
Sign Up

Learn About Plaque Psoriasis

What is the definition of Plaque Psoriasis?
Plaque psoriasis is the most common form of psoriasis. Psoriasis is an autoimmune skin disorder that affects the growth rate of skin cells. Plaque psoriasis causes raised, reddened dry skin patches with silvery scales that appear on the scalp, elbows, knees, trunk and back.
What are the symptoms of Plaque Psoriasis?
Plaque psoriasis appears in cycles, with periods of remission followed by flare-ups that can last from weeks to months. Symptoms of plaque psoriasis during flare-ups can include reddened, dry skin patches covered in thick silvery scales, usually on the elbows, arms, knees, abdomen, and back, that may cause itching, burning, or bleeding. The sizes of the psoriasis plaques can range from small spots to covering large areas of the body. Nearly half of patients with psoriasis also have abnormal, thickened nails that are pitted or ridged. Psoriasis can also affect the mouth or genitals.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Plaque Psoriasis?
There is currently no cure for plaque psoriasis. Treatments for plaque psoriasis include topical therapy, such as corticosteroids, Vitamin D analogues, retinoids, calcineurin inhibitors, salicylic acid, coal tar, Goeckerman therapy, and anthralin; light therapy; other oral or injected medications; biologics; and alternative therapies.
Who are the top Plaque Psoriasis Local Doctors?
Elite in Plaque Psoriasis
Dr. Andrew Blauvelt
Dermatology
Elite in Plaque Psoriasis
Dr. Andrew Blauvelt
Dermatology

James W. Baker MD LLC

9495 SW Locust St Ste A, 
Portland, OR 
503-445-2200
Languages Spoken:
English
See accepted insurances

Andrew Blauvelt is a Dermatologist practicing medicine in Portland, Oregon. Dr. Blauvelt is rated as an Elite provider by MediFind in the treatment of Plaque Psoriasis. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Plaque Psoriasis, Psoriasis, Atopic Dermatitis, and Actinic Keratosis.

Elite in Plaque Psoriasis
Dr. Philip J. Mease
Rheumatology
Elite in Plaque Psoriasis
Dr. Philip J. Mease
Rheumatology
601 Broadway, 
Seattle, WA 
206-386-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Philip Mease is a Rheumatologist practicing medicine in Seattle, Washington. Dr. Mease is rated as an Elite provider by MediFind in the treatment of Plaque Psoriasis. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Psoriatic Arthritis, Arthritis, Psoriasis, and Axial Spondyloarthritis (AxSpA). Dr. Mease is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Plaque Psoriasis
Dr. Craig Leonardi
Dermatology
Elite in Plaque Psoriasis
Dr. Craig Leonardi
Dermatology

Central Dermatology P.C.

1034 S Brentwood Blvd Ste 600, 
Saint Louis, MO 
314-721-5565
Languages Spoken:
English
See accepted insurances

Craig Leonardi is a Dermatologist practicing medicine in Saint Louis, Missouri. Dr. Leonardi is rated as an Elite provider by MediFind in the treatment of Plaque Psoriasis. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Psoriasis, Plaque Psoriasis, Atopic Dermatitis, and Contact Dermatitis.

View All Doctors
What are the latest Plaque Psoriasis Clinical Trials?
The Real-World Impact of Risankizumab on the Quality of Life and Cumulative Life Course Impairment (CLCI) in Patients With Moderate-to-Severe Plaque Psoriasis (DREAM)
The Real-World Impact of Risankizumab on the Quality of Life and Cumulative Life Course Impairment (CLCI) in Patients With Moderate-to-Severe Plaque Psoriasis (DREAM)
Enrollment Status: Recruiting
Publish Date: April 16, 2026

Summary: Psoriasis is a chronic, systemic, inflammatory disease in which skin cells build up and develop thick, red and white scaly patches on the skin. This study will assess the change in quality of life of risankizumab treatment in adult participants with moderate to severe plaque psoriasis real-world clinical practice. Risankizumab is an approved drug for treating participants with Psoriasis. Approxima...

Match to trials
Find the right clinical trials for you in under a minute
Get started
An Open-label, Parallel Group, Multicenter Study Evaluating the Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants With Moderate to Severe Plaque Psoriasis
An Open-label, Parallel Group, Multicenter Study Evaluating the Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants With Moderate to Severe Plaque Psoriasis
Enrollment Status: Recruiting
Publish Date: April 16, 2026
Intervention Type: Drug
Study Phase: Not Applicable

Summary: The purpose of this study is to evaluate the efficacy, safety, tolerability and drug survival of guselkumab in high-dose and extended-interval versus standard-dose in Chinese participants with moderate to severe plaque psoriasis.

View All Clinical Trials